IMP dehydrogenase from Pneumocystis carinii as a potential drug target

Mary Jeanne O'Gara, Chao Hung Lee, Geoffrey A. Weinberg, Jeniece M. Nott, Sherry F. Queener

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Mycophenolic acid, a specific inhibitor of IMP dehydrogenase (IMPDH; EC 1.1.1.205), is a potent inhibitor of Pneumocystis carinii growth in culture, suggesting that IMPDH may he a sensitive target for chemotherapy in this organism. The IMPDH gene was cloned as a first step to characterizing the enzyme and developing selective inhibitors. A 1.3-kb fragment containing a portion of the P. carinii IMPDH gene was amplified by PCR with two degenerate oligonucleotides based on conserved sequences in IMPDH from humans and four different microorganisms. Northern hybridization analysis showed the P. carinii IMPDH mRNA to be approximately 1.6 kb. The entire cDNA encoding P. carinii IMPDH was isolated and cloned. The deduced amino acid sequence of P. carinii IMPDH shared homology with bacterial (31 to 38%), protozoal (48 to 59%), mammalian (60 to 62%), and fungal (62%) IMPDH enzymes. The IMPDH cDNA was expressed by using a T7 expression system in an IMPDH-deficient strain of Escherichia coli (strain Sφ1101). E. coli Sφ1101 cells containing the P. carinii IMPDH gene were able to grow on medium lacking guanine, implying that the protein expressed in vivo was functional. Extracts of these E. coli cells contained IMPDH activity that had an apparent K(m) for IMP of 21.7 ± 0.3 μM and an apparent K(m) for NAD of 314 ± 84 μM (mean ± standard error of the mean; n = 3), and the activity was inhibited by mycophenolic acid (50% inhibitory concentration, 24 μM; n = 2).

Original languageEnglish (US)
Pages (from-to)40-48
Number of pages9
JournalAntimicrobial Agents and Chemotherapy
Volume41
Issue number1
StatePublished - Jan 1 1997

Fingerprint

IMP Dehydrogenase
Pneumocystis carinii
Pharmaceutical Preparations
Mycophenolic Acid
Escherichia coli
Complementary DNA
Genes
Inosine Monophosphate
Conserved Sequence
Guanine
Enzymes
Oligonucleotides
NAD
Inhibitory Concentration 50
Amino Acid Sequence
Drug Therapy
Polymerase Chain Reaction
Messenger RNA
Growth

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

IMP dehydrogenase from Pneumocystis carinii as a potential drug target. / O'Gara, Mary Jeanne; Lee, Chao Hung; Weinberg, Geoffrey A.; Nott, Jeniece M.; Queener, Sherry F.

In: Antimicrobial Agents and Chemotherapy, Vol. 41, No. 1, 01.01.1997, p. 40-48.

Research output: Contribution to journalArticle

O'Gara, MJ, Lee, CH, Weinberg, GA, Nott, JM & Queener, SF 1997, 'IMP dehydrogenase from Pneumocystis carinii as a potential drug target', Antimicrobial Agents and Chemotherapy, vol. 41, no. 1, pp. 40-48.
O'Gara, Mary Jeanne ; Lee, Chao Hung ; Weinberg, Geoffrey A. ; Nott, Jeniece M. ; Queener, Sherry F. / IMP dehydrogenase from Pneumocystis carinii as a potential drug target. In: Antimicrobial Agents and Chemotherapy. 1997 ; Vol. 41, No. 1. pp. 40-48.
@article{5a7210096c6949e28a868e36b16051ef,
title = "IMP dehydrogenase from Pneumocystis carinii as a potential drug target",
abstract = "Mycophenolic acid, a specific inhibitor of IMP dehydrogenase (IMPDH; EC 1.1.1.205), is a potent inhibitor of Pneumocystis carinii growth in culture, suggesting that IMPDH may he a sensitive target for chemotherapy in this organism. The IMPDH gene was cloned as a first step to characterizing the enzyme and developing selective inhibitors. A 1.3-kb fragment containing a portion of the P. carinii IMPDH gene was amplified by PCR with two degenerate oligonucleotides based on conserved sequences in IMPDH from humans and four different microorganisms. Northern hybridization analysis showed the P. carinii IMPDH mRNA to be approximately 1.6 kb. The entire cDNA encoding P. carinii IMPDH was isolated and cloned. The deduced amino acid sequence of P. carinii IMPDH shared homology with bacterial (31 to 38{\%}), protozoal (48 to 59{\%}), mammalian (60 to 62{\%}), and fungal (62{\%}) IMPDH enzymes. The IMPDH cDNA was expressed by using a T7 expression system in an IMPDH-deficient strain of Escherichia coli (strain Sφ1101). E. coli Sφ1101 cells containing the P. carinii IMPDH gene were able to grow on medium lacking guanine, implying that the protein expressed in vivo was functional. Extracts of these E. coli cells contained IMPDH activity that had an apparent K(m) for IMP of 21.7 ± 0.3 μM and an apparent K(m) for NAD of 314 ± 84 μM (mean ± standard error of the mean; n = 3), and the activity was inhibited by mycophenolic acid (50{\%} inhibitory concentration, 24 μM; n = 2).",
author = "O'Gara, {Mary Jeanne} and Lee, {Chao Hung} and Weinberg, {Geoffrey A.} and Nott, {Jeniece M.} and Queener, {Sherry F.}",
year = "1997",
month = "1",
day = "1",
language = "English (US)",
volume = "41",
pages = "40--48",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "1",

}

TY - JOUR

T1 - IMP dehydrogenase from Pneumocystis carinii as a potential drug target

AU - O'Gara, Mary Jeanne

AU - Lee, Chao Hung

AU - Weinberg, Geoffrey A.

AU - Nott, Jeniece M.

AU - Queener, Sherry F.

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Mycophenolic acid, a specific inhibitor of IMP dehydrogenase (IMPDH; EC 1.1.1.205), is a potent inhibitor of Pneumocystis carinii growth in culture, suggesting that IMPDH may he a sensitive target for chemotherapy in this organism. The IMPDH gene was cloned as a first step to characterizing the enzyme and developing selective inhibitors. A 1.3-kb fragment containing a portion of the P. carinii IMPDH gene was amplified by PCR with two degenerate oligonucleotides based on conserved sequences in IMPDH from humans and four different microorganisms. Northern hybridization analysis showed the P. carinii IMPDH mRNA to be approximately 1.6 kb. The entire cDNA encoding P. carinii IMPDH was isolated and cloned. The deduced amino acid sequence of P. carinii IMPDH shared homology with bacterial (31 to 38%), protozoal (48 to 59%), mammalian (60 to 62%), and fungal (62%) IMPDH enzymes. The IMPDH cDNA was expressed by using a T7 expression system in an IMPDH-deficient strain of Escherichia coli (strain Sφ1101). E. coli Sφ1101 cells containing the P. carinii IMPDH gene were able to grow on medium lacking guanine, implying that the protein expressed in vivo was functional. Extracts of these E. coli cells contained IMPDH activity that had an apparent K(m) for IMP of 21.7 ± 0.3 μM and an apparent K(m) for NAD of 314 ± 84 μM (mean ± standard error of the mean; n = 3), and the activity was inhibited by mycophenolic acid (50% inhibitory concentration, 24 μM; n = 2).

AB - Mycophenolic acid, a specific inhibitor of IMP dehydrogenase (IMPDH; EC 1.1.1.205), is a potent inhibitor of Pneumocystis carinii growth in culture, suggesting that IMPDH may he a sensitive target for chemotherapy in this organism. The IMPDH gene was cloned as a first step to characterizing the enzyme and developing selective inhibitors. A 1.3-kb fragment containing a portion of the P. carinii IMPDH gene was amplified by PCR with two degenerate oligonucleotides based on conserved sequences in IMPDH from humans and four different microorganisms. Northern hybridization analysis showed the P. carinii IMPDH mRNA to be approximately 1.6 kb. The entire cDNA encoding P. carinii IMPDH was isolated and cloned. The deduced amino acid sequence of P. carinii IMPDH shared homology with bacterial (31 to 38%), protozoal (48 to 59%), mammalian (60 to 62%), and fungal (62%) IMPDH enzymes. The IMPDH cDNA was expressed by using a T7 expression system in an IMPDH-deficient strain of Escherichia coli (strain Sφ1101). E. coli Sφ1101 cells containing the P. carinii IMPDH gene were able to grow on medium lacking guanine, implying that the protein expressed in vivo was functional. Extracts of these E. coli cells contained IMPDH activity that had an apparent K(m) for IMP of 21.7 ± 0.3 μM and an apparent K(m) for NAD of 314 ± 84 μM (mean ± standard error of the mean; n = 3), and the activity was inhibited by mycophenolic acid (50% inhibitory concentration, 24 μM; n = 2).

UR - http://www.scopus.com/inward/record.url?scp=0031038391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031038391&partnerID=8YFLogxK

M3 - Article

C2 - 8980752

AN - SCOPUS:0031038391

VL - 41

SP - 40

EP - 48

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 1

ER -